Balchem Corp— Sankey Diagram
Quarterly mode · period ending 2026-03-31 · SEC EDGAR
ComparingFY2026 (Q4) vs FY2025 (Q4)
Revenue
$271M
↑+8.1% +$20Mvs FY2025 (Q4)
Gross Profit
$101M
↑+14.6% +$13Mvs FY2025 (Q4)
Operating Income
$56M
↑+9.0% +$5Mvs FY2025 (Q4)
Net Income
$40M
↑+8.7% +$3Mvs FY2025 (Q4)
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2026 (Q4) | FY2025 (Q4) |
|---|---|---|
| Revenue | $271M | $251M |
| COGS | $170M | $162M |
| Gross Profit | $101M | $88M |
| R&D | $6M | $5M |
| SG&A | $0 | $0 |
| D&A | $12M | $11M |
| Other OpEx | $27M | $21M |
| Operating Income | $56M | $51M |
| Interest Exp. | $3M | $3M |
| Other Non-Op | $0 | $0 |
| Pretax Income | $53M | $48M |
| Tax | $12M | $11M |
| Net Income | $40M | $37M |
QuarterCharts · SEC EDGAR data · BCPC · Comparing FY2026 (Q4) vs FY2025 (Q4)